PATENT CLAIM ANALYSIS

Application Number: 15887243
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "567000"]

Abstract:
The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.

Claim (Index 24):
The pharmaceutical composition of  claim 23 , wherein said composition comprises less than 1 \u03bcg of hydrazine per mg of carbidopa after said 12 month storage.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15448208', '15001392', '15507959', '14633545', '14189559']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.751647577795766
- 35 USC 102 Novelty (BERT): 0.5750462587328716
- Combined Prediction Score: 0.7339874458894766
- Mean Citation Score: 254.065604
- Max Citation Score: 505.5894
- Similarity Product: 317.2986328975081

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test